Component: (Network and Table)
Network
00400 - Statement - Consolidated Statements Of Cash Flows
(http://www.uqm.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000315449 (http://www.sec.gov/CIK)
Consolidated Statements of Cash FlowsPeriod [Axis]
2015-04-01 - 2016-03-31
2014-04-01 - 2015-03-31
2013-04-01 - 2014-03-31
Consolidated Statements of Cash Flows
 
 
 
Cash flows from operating activities:
 
 
 
Net loss
(6,938,351) 
(5,988,530) 
(2,773,244) 
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
Depreciation and amortization
950,145  
1,061,312  
1,136,021  
Non-cash equity based compensation
595,854  
687,709  
789,871  
Recovery of impaired assets
(585,800) 
 
(868,475) 
Loss (gain) on disposal of long-lived assets
 
1,219  
(37,462) 
Impairment of inventories
9,906  
44,451  
5,047  
Change in operating assets and liabilities:
 
 
 
Accounts receivable
41,013  
328,080  
1,218,971  
Other receivable
855,000  
(855,000) 
 
Costs and estimated earnings on uncompleted contracts
(10,379) 
291,338  
(162,991) 
Inventories
232,706  
655,918  
938,992  
Prepaid expenses and other current assets
(6,149) 
(2,460) 
45,969  
Accounts payable and other current liabilities
(7,463) 
65,501  
(470,119) 
Billings in excess of costs and estimated earnings on uncompleted contracts
(84,444) 
84,444  
 
Other long-term liabilities
(156,135) 
262,924  
(445,312) 
Net cash used in operating activities
(5,104,097) 
 
(3,363,094) 
 
(622,732) 
 
Cash flows from investing activities:
 
 
 
Purchases of short-term investments
  
(593) 
Maturities of short-term investments
 
63,029  
 
Acquisition of property and equipment
(144,522) 
(558,755) 
(377,224) 
Property and equipment reimbursements received from DOE under grant
 
371,140  
215,754  
Increase in patent and trademark costs
(32,103) 
(28,541) 
(54,721) 
Cash proceeds from the sale of equipment
  
1,565,032  
Net cash (used in) provided by investing activities
(176,625) 
 
(153,127) 
 
1,348,248  
 
Cash flows from financing activities:
 
 
 
Cash received for shares exercised under employee stock purchase plan
39,377  
4,497  
21,075  
Cash received for exercise of employee options
 
22,055  
60,689  
Issuance of common stock in registered direct offering, net of offering costs
5,778,463  
 
4,911,933  
Payment of employee tax withholdings in exchange for return of common stock
(92,591) 
(171,740) 
 
Net cash (used in) provided by financing activities
5,725,249  
 
(145,188) 
 
4,993,697  
 
Increase (decrease) in cash and cash equivalents
444,527  
 
(3,661,409) 
 
5,719,213  
 
Cash and cash equivalents at beginning of period
6,585,703  
10,247,112  
4,527,899  
Cash and cash equivalents at end of period
7,030,230  
 
6,585,703  
 
10,247,112